Posted by admin on Jul 27th, 2022
Park Avenue Securities LLC boosted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) by 21.3% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 6,123 shares of the medical instruments supplier’s stock after buying an additional 1,075 shares during the quarter. Park Avenue Securities LLC’s holdings in DENTSPLY SIRONA were worth $301,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. State of Michigan Retirement System lifted its stake in DENTSPLY SIRONA by 0.4% in the 4th quarter. State of Michigan Retirement System now owns 55,049 shares of the medical instruments supplier’s stock valued at $3,071,000 after buying an additional 200 shares in the last quarter. Mutual of America Capital Management LLC lifted its stake in DENTSPLY SIRONA by 0.7% in the 4th quarter. Mutual of America Capital Management LLC now owns 28,920 shares of the medical instruments supplier’s stock valued at $1,613,000 after buying an additional 201 shares in the last quarter. Signaturefd LLC lifted its stake in DENTSPLY SIRONA by 13.0% in the 4th quarter. Signaturefd LLC now owns 1,786 shares of the medical instruments supplier’s stock valued at $100,000 after buying an additional 205 shares in the last quarter. Northwest Investment Counselors LLC lifted its stake in DENTSPLY SIRONA by 1.4% in the 1st quarter. Northwest Investment Counselors LLC now owns 15,756 shares of the medical instruments supplier’s stock valued at $776,000 after buying an additional 217 shares in the last quarter. Finally, Fifth Third Bancorp lifted its stake in DENTSPLY SIRONA by 0.7% in the 4th quarter. Fifth Third Bancorp now owns 31,816 shares of the medical instruments supplier’s stock valued at $1,775,000 after buying an additional 222 shares in the last quarter. Hedge funds and other institutional investors own 94.79% of the company’s stock.
Shares of NASDAQ XRAY opened at $35.83 on Wednesday. DENTSPLY SIRONA Inc. has a 12-month low of $33.78 and a 12-month high of $66.98. The company has a market cap of $7.72 billion, a P/E ratio of 21.20 and a beta of 0.94. The company has a current ratio of 1.45, a quick ratio of 1.03 and a debt-to-equity ratio of 0.38. The stock has a fifty day moving average price of $36.91 and a 200 day moving average price of $44.91.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last announced its quarterly earnings results on Tuesday, May 10th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a return on equity of 11.63% and a net margin of 8.81%. The firm had revenue of $9.67 billion during the quarter, compared to the consensus estimate of $982.05 million. During the same period in the prior year, the firm earned $0.72 EPS. The firm’s quarterly revenue was up 841.1% compared to the same quarter last year. Research analysts anticipate that DENTSPLY SIRONA Inc. will post 2.41 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Friday, July 8th. Stockholders of record on Friday, June 24th were paid a dividend of $0.125 per share. The ex-dividend date was Thursday, June 23rd. This represents a $0.50 annualized dividend and a dividend yield of 1.40%. DENTSPLY SIRONA’s dividend payout ratio is presently 29.59%.
In other news, Director Eric Brandt sold 6,900 shares of the firm’s stock in a transaction dated Tuesday, May 3rd. The stock was sold at an average price of $39.71, for a total transaction of $273,999.00. Following the completion of the sale, the director now directly owns 35,155 shares in the company, valued at $1,396,005.05. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.76% of the company’s stock.
A number of research analysts have weighed in on the company. The Goldman Sachs Group reduced their price target on DENTSPLY SIRONA from $42.00 to $41.00 and set a “neutral” rating on the stock in a research note on Thursday, July 21st. HC Wainwright reduced their price target on DENTSPLY SIRONA from $58.00 to $48.00 and set a “hold” rating on the stock in a research note on Friday, April 22nd. Morgan Stanley reduced their price target on DENTSPLY SIRONA from $48.00 to $44.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 20th. Piper Sandler reduced their price target on DENTSPLY SIRONA from $41.00 to $38.00 in a research note on Monday, July 11th. Finally, William Blair downgraded DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Tuesday, April 19th. Six investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $48.11.
DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.
Park Avenue Securities LLC Acquires 2,120 Shares of Apollo Global Management, Inc. (NYSE:APO)
SG Americas Securities LLC Has $1.75 Million Position in Ellington Financial Inc. (NYSE:EFC)